drugset / Trial / NCT04911062
HTX-011 in Spinal Surgery
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a Phase 2, multicenter study in subjects undergoing an open lumbar decompression surgery.
Timeline
- Start
- 2022-04-07
- Primary completion
- 2022-07-29
- Completion
- 2022-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 100 mg | Other |
| Subject | Bupivacaine | Other / unclassified | 200 mg | Other |
| Subject | Meloxicam | Small molecule | 6 mg | Other |
Indications
No indication recorded.